DOCU vs. PATH, TWLO, ESTC, PCOR, CFLT, GEN, DUOL, SPSC, KVYO, and BRZE
Should you be buying DocuSign stock or one of its competitors? The main competitors of DocuSign include UiPath (PATH), Twilio (TWLO), Elastic (ESTC), Procore Technologies (PCOR), Confluent (CFLT), Gen Digital (GEN), Duolingo (DUOL), SPS Commerce (SPSC), Klaviyo (KVYO), and Braze (BRZE). These companies are all part of the "prepackaged software" industry.
UiPath (NYSE:PATH) and DocuSign (NASDAQ:DOCU) are both large-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.
UiPath has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, DocuSign has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.
62.5% of UiPath shares are owned by institutional investors. Comparatively, 77.6% of DocuSign shares are owned by institutional investors. 22.4% of UiPath shares are owned by company insiders. Comparatively, 1.7% of DocuSign shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
DocuSign has higher revenue and earnings than UiPath. UiPath is trading at a lower price-to-earnings ratio than DocuSign, indicating that it is currently the more affordable of the two stocks.
DocuSign has a net margin of 2.68% compared to DocuSign's net margin of -6.87%. UiPath's return on equity of 13.91% beat DocuSign's return on equity.
DocuSign received 287 more outperform votes than UiPath when rated by MarketBeat users. Likewise, 59.71% of users gave DocuSign an outperform vote while only 45.13% of users gave UiPath an outperform vote.
UiPath presently has a consensus target price of $27.41, suggesting a potential upside of 34.31%. DocuSign has a consensus target price of $60.25, suggesting a potential upside of 0.06%. Given DocuSign's stronger consensus rating and higher probable upside, analysts plainly believe UiPath is more favorable than DocuSign.
In the previous week, UiPath had 8 more articles in the media than DocuSign. MarketBeat recorded 16 mentions for UiPath and 8 mentions for DocuSign. DocuSign's average media sentiment score of 0.80 beat UiPath's score of 0.22 indicating that UiPath is being referred to more favorably in the media.
Summary
DocuSign beats UiPath on 10 of the 18 factors compared between the two stocks.
Get DocuSign News Delivered to You Automatically
Sign up to receive the latest news and ratings for DOCU and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DOCU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
DocuSign Competitors List
Related Companies and Tools